PL435319A1 - Sposób otrzymywania hialuronidazy oraz produkt otrzymany tym sposobem - Google Patents

Sposób otrzymywania hialuronidazy oraz produkt otrzymany tym sposobem

Info

Publication number
PL435319A1
PL435319A1 PL435319A PL43531920A PL435319A1 PL 435319 A1 PL435319 A1 PL 435319A1 PL 435319 A PL435319 A PL 435319A PL 43531920 A PL43531920 A PL 43531920A PL 435319 A1 PL435319 A1 PL 435319A1
Authority
PL
Poland
Prior art keywords
product obtained
concentration
filtration
ballast
ultrafiltration
Prior art date
Application number
PL435319A
Other languages
English (en)
Other versions
PL244350B1 (pl
Inventor
Monika BESMAN
Magdalena MATWIEJCZYK
Grzegorz CIURA
Filip Porzucek
Konrad BABIJ
Michał ŁOBOCKI
Original Assignee
Pharmfactor Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmfactor Spółka Z Ograniczoną Odpowiedzialnością filed Critical Pharmfactor Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL435319A priority Critical patent/PL244350B1/pl
Priority to EP21810152.5A priority patent/EP4240838A1/en
Priority to PCT/PL2021/050066 priority patent/WO2022060235A1/en
Publication of PL435319A1 publication Critical patent/PL435319A1/pl
Publication of PL244350B1 publication Critical patent/PL244350B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2474—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/12—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the preparation of the feed
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • B01D61/146—Ultrafiltration comprising multiple ultrafiltration steps
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01035—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/04—Specific process operations in the feed stream; Feed pretreatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/06—Specific process operations in the permeate stream
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/12—Addition of chemical agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/26—Further operations combined with membrane separation processes
    • B01D2311/2623—Ion-Exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/26—Further operations combined with membrane separation processes
    • B01D2311/2676—Centrifugal separation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/26—Further operations combined with membrane separation processes
    • B01D2311/2697—Chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Water Supply & Treatment (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Przedmiotem wynalazku jest sposób otrzymywania hialuronidazy zawierający kolejno etapy: rozdrobnienie tkanki, ekstrakcja, precypitacja balastów, filtracja, zatężanie I, inkubacja, ultrafiltracja I, zatężanie II, wysalanie balastów, wirowanie, chromatografia I sączenie żelowe, chromatografia II cieczowa jonowymienna, ultrafiltracja II, zatężanie III, filtracja wyjaławiająca i suszenie. Przedmiotem wynalazku jest również produkt otrzymany tym sposobem.
PL435319A 2020-09-15 2020-09-15 Sposób otrzymywania hialuronidazy ze zwierzęcych jąder oraz produkt otrzymany tym sposobem PL244350B1 (pl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL435319A PL244350B1 (pl) 2020-09-15 2020-09-15 Sposób otrzymywania hialuronidazy ze zwierzęcych jąder oraz produkt otrzymany tym sposobem
EP21810152.5A EP4240838A1 (en) 2020-09-15 2021-09-14 Method of obtaining hyaluronidase from bovine testes
PCT/PL2021/050066 WO2022060235A1 (en) 2020-09-15 2021-09-14 Method of obtaining hyaluronidase from bovine testes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL435319A PL244350B1 (pl) 2020-09-15 2020-09-15 Sposób otrzymywania hialuronidazy ze zwierzęcych jąder oraz produkt otrzymany tym sposobem

Publications (2)

Publication Number Publication Date
PL435319A1 true PL435319A1 (pl) 2022-03-21
PL244350B1 PL244350B1 (pl) 2024-01-15

Family

ID=78650030

Family Applications (1)

Application Number Title Priority Date Filing Date
PL435319A PL244350B1 (pl) 2020-09-15 2020-09-15 Sposób otrzymywania hialuronidazy ze zwierzęcych jąder oraz produkt otrzymany tym sposobem

Country Status (3)

Country Link
EP (1) EP4240838A1 (pl)
PL (1) PL244350B1 (pl)
WO (1) WO2022060235A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102528707B1 (ko) * 2022-11-01 2023-05-04 한국코러스 주식회사 고순도의 히알루로니다제 정제 방법
CN117165558B (zh) * 2023-09-27 2024-07-09 四川德博尔制药有限公司 一种透明质酸酶的制备方法
CN117723682B (zh) * 2023-11-20 2024-06-11 山东丰金美业科技有限公司 一种交联透明质酸或其盐凝胶交联度的检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2027759C1 (ru) * 1992-02-03 1995-01-27 Пак Владимир Николаевич Способ получения гиалуронидазы

Also Published As

Publication number Publication date
PL244350B1 (pl) 2024-01-15
WO2022060235A1 (en) 2022-03-24
EP4240838A1 (en) 2023-09-13

Similar Documents

Publication Publication Date Title
EP4656242A3 (en) Compositions and methods of treating muscle dystrophy
NO20054769L (no) Substituerte fenylalkansyrer
CY1109471T1 (el) Μεθοδοι και μεσα για την παραγωγη υαλουρονανης
DOP2011000045A (es) Anticuerpos monoclonales contra el inhibidor de la via del factor tisular (tfpi)
EA201390739A1 (ru) Способ лечения fgf21-ассоциированных расстройств
BR112013020992A2 (pt) aparelho e método para isolamento de leucócitos e células tumorosas por meio de filtração
EA201171200A1 (ru) Полиморфы элтромбопага и солей элтромбопага, а также способы их получения
PE20211114A1 (es) Metodos y composiciones para terapia con celulas oculares
BR112022023697A2 (pt) Métodos e meios para a produção de moléculas semelhantes a ig
BR112023002455A2 (pt) Anticorpos fgfr3 e métodos de uso
NO20053357L (no) Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse.
EA200900859A1 (ru) Способ производства сыра
NZ599442A (en) Allergy treatment using acid treated aqueous whey protein extract
EA202091476A1 (ru) Кисломолочный продукт и его приготовление с использованием фосфолипазы
EA200970387A1 (ru) Соль п-толуолсульфокислоты 5-амино-3-(2`-о-ацетил-3`-дезокси-бета-d-рибофуранозил)-3н-тиазоло[4,5-d]пиримидин-2-она и способы получения
MX2025005500A (es) Anticuerpos anti proteína plasmática a asociada al embarazo (papp-a) y métodos de uso de estos
EA200700852A1 (ru) Новый способ получения пищевых продуктов
EA202193038A1 (ru) Антитела против sema3a и их применения для лечения заболеваний глаз
DE60124526D1 (de) Methode zur identifizierung von helicobacter antigenen
PH12022552041A1 (en) Anti-axl antibodies and compositions
MX2019012871A (es) Variantes de proteina morfogenica osea humana 7 (bmp7).
WO2023082523A1 (zh) 一种提高罗非鱼头骨制备硫酸软骨素提取率的方法
MX2023010692A (es) Compuestos que tienen tetrahidroindolizina-1-carboxamida como inhibidores de bcl-2.
ZA202501671B (en) Methods of treating graves' disease using anti-fcrn antibodies
ZA202309205B (en) Method for treating human or animal urine by basifiication and uses of the urine obtained in particular as fertilising substance